Michael Kahn

President & Founder

With over 10 years of experience in the pharmaceutical and academic research fields, Michael brings a wide range of laboratory and teaching experience to MCR Labs. His scientific background and leadership skills make him an integral part of lab operations and community outreach efforts. Michael has been an advocate for product safety and efficacy through reliable testing in the MMJ industry since entering the cannabis space.

He has spoken publicly for the right of MMJ consumers to access testing results that current scientific practices can provide. Michael is committed to ensuring that MCR Labs is a leader in reliable and trusted cannabis research and testing. He earned an MS in Chemistry from Boston University, BA/MS degrees in Chemistry and BA in Physics from Brandeis University in Waltham, MA.

Jonathan Wani

Director of Community & Client Relations

Jon brings a wealth of cannabis knowledge to MCR Labs. He has been a part of the cannabis community for over a decade while studying genetic lineages, plant physiology, and structure of cannabis.

Jon’s technical expertise and knowledge of testing procedures and regulations allow him to effectively communicate with clients to ensure they receive excellent customer service.  Jon received his BA in English from Plymouth State University.

Scott Churchill

Director of Compliance & Methodology

Scott brings over fifteen years of diverse industrial and pharmaceutical experience to MCR Labs.  By leveraging his experience in management, quality assurance, and analytical chemistry, Scott ensures MCR Labs meets or exceeds regulatory compliance requirements, achieves operational excellence, and maintains leading-edge technological capabilities.

In the pharmaceutical research field, Scott was a formulation scientist, a quality assurance expert, and an analytical method development scientist. Scott understands that scientists are the most important asset of any analytical testing operation. To this end, he instituted a company-wide training program to ensure a high level of quality for all performed operations. Scott has a degree in chemistry from Rivier College.

Ross Gutman

Director of Finance

Ross is a finance and accounting professional with over 10 years of experience in Financial Operations, Business Strategy, and Quantitative Analysis and has worked in positions of increasing responsibility in Public Accounting and Corporate environments. Most recently Ross served as the Canada business unit Controller and CFO for a multi-brand organization with $300 million in annual revenues. He brings a wealth of experience with budgeting, revenue forecasting, cost management, financial reporting, analytics, and Six Sigma process improvement methodologies to MCR Labs.

Ross holds an MBA from Carnegie Mellon University’s Tepper Graduate School of Business. He also has a Masters in Taxation, a Graduate Certificate in Financial Planning from Bentley University’s McCallum Graduate School of Business, as well as a Bachelors in Accounting from Bentley University.

Ross is also a frequent guest lecturer and start-up advisor at MIT’s eClub.

Advisory Board


Dimitrios Karouta

Business Management

Dimitri brings experience in new business development, product development, and financial planning to our advisory board. Dimitri provides input to MCR Labs regarding business operations, financial planning, and strategic resource management.

Dimitri earned a degree in Business Management from Northeastern University.  He has experience working as a Project Manager in business settings, and he has founded and maintained several successful local small businesses.

Dr. Michael Frid

Pharmaceutical Sciences

Michael Frid brings 15 years of pharmaceutical industry experience and perspective to bear, including his background as a lead scientist and years of experience collaborating with a broad array of biopharmaceutical companies on pre-clinical and clinical stage projects. He has extensive experience and expertise in physicochemical characterization and formulation development for a variety of administration routes.

Dr. Frid is an organic chemist and is an expert in drug discovery and early drug development.

He has co-authored several publications in peer-reviewed journals, has given presentations to audiences of pharmaceutical professionals, and has written on the subjects of drug formulation development, salt selection, and outsourcing. Dr. Frid has also served as a reviewer for the American Association of Pharmaceutical Scientists (AAPS).

Dr. Frid received his Ph.D. in Organic Chemistry from the Massachusetts Institute of Technology (MIT) and his B.S. in Chemistry Cum Laude from New York University (NYU).